Benicar Efficacy: New Investigative Findings show Olmesartan medoxomil safely and effectively Reduces blood pressure Compared with placebo in a clinical Evaluation of patients with stage 1 and stage 2 hypertenion

Trial Profile

Benicar Efficacy: New Investigative Findings show Olmesartan medoxomil safely and effectively Reduces blood pressure Compared with placebo in a clinical Evaluation of patients with stage 1 and stage 2 hypertenion

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Aug 2010

At a glance

  • Drugs Olmesartan medoxomil; Olmesartan medoxomil/hydrochlorothiazide
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms BENIFORCE
  • Most Recent Events

    • 17 Aug 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top